AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04063553 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Volunteers Service
Description: Subjects in the intervention group will receive standard physiotherapy care and an additional volunteers session once a day for at least 3 times during their stay in the hospital. The volunteer will set up the TKR exercise video for the subjects, then supervise or guide the subjects with the exercises.~All volunteers are recruited from TTSH volunteers pool managed by Center of Health Activation (CHA). TKR volunteers are trained by the study team, including a formal classroom session and a practical and role play session. After the training, volunteers need to pass 3 assessment by the physiotherapists in order to attend to patients independently by themselves. Volunteers who are bilingual will attend to the subject alone, or else those who can only converse in Chinese/ English will pair up with another volunteer who knows another language to make sure there is no communication barrier between volunteers and patients.
Study NCT03845517 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06700841 15 mg
Description: PF-06700841 15 mg
Study NCT03845517 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06700841 30 mg
Description: PF-06700841 30 mg
Study NCT03845517 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06700841 45 mg
Description: PF-06700841 45 mg
Study NCT05560945 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.32% Sodium Fluoride Dentifrice Toothpaste
Description: Toothpaste
Study NCT05560945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1.5% Arginine Dentifrice
Description: Toothpaste
Study NCT05560945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 8.0% Arginine Dentifrice
Description: Toothpaste
Study NCT00183599 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 5 Minutes of Simple Advice
Study NCT00183599 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Study NCT00183599 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Study NCT04306445 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: GF-IGB: Obalon Balloon
Description: The balloon, which is attached to a thin catheter, is swallowed by the patient in a standing position. Once the two-step verification of balloon passage into the stomach by both fluoroscopy and pressure reading, the balloon is inflated to a volume of 250 ml with a nitrogen-mix gas, additional imaging of the inflated balloon is obtained, the catheter is ejected from the balloon, and the catheter is pulled out through the patient's mouth. The process is repeated at week 2 for the second balloon and between weeks 4-8 for the third balloon. All patients are given an individualized calorie prescription by a registered dietitian for a goal of up to 2 pounds of weight loss per week. The balloons are removed endoscopically 6 months after placement of the first balloon. Patients also attend monthly virtual individual diet coaching and monthly virtual group behavior coaching sessions both delivered by a registered dietitian for twelve months focused on long-term behavior change.
Study NCT04306445 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Medically Supervised Meal Replacement Program: My New Weigh
Description: Patients are given an individualized calorie prescription by a registered dietitian for a goal of 2 pounds weight loss per week. Patients are seen in a group-based program once a week focused on long-term behavior change and use meal replacements for a nutritionally balanced very low-calorie diet for 20 weeks. 4-5 meal replacements are consumed per day. If only 4 meal replacements are consumed, individuals eat 3 servings of vegetables and 2 servings of fruit per day as well.
Study NCT04306445 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic sleeve gastroplasty: (ESG)
Description: Endoscopic sleeve gastroplasty is a weight loss procedure that uses an FDA 510K cleared endoscopic suturing device known as Overstitch to reduce the size of the gastric body. The procedure is completed with an endoscope. It is inserted through the mouth, down the esophagus, and into the stomach. Sutures with 8-10 bites 1.5-2 cm apart in a U-shape pattern are placed starting distally 6 cm proximal to the pylorus. Additional sutures are placed moving proximally up to 2 cm distal to the gastroesophageal junction. An additional row of sutures is then placed again in the distal to proximal stomach to complete the gastroplasty. All patients are given an individualized calorie prescription by a registered dietitian for a goal of up to 2 pounds of weight loss per week. Patients also attend monthly virtual individual diet coaching and monthly virtual group behavior coaching sessions both delivered by a registered dietitian for twelve months focused on long-term behavior change.
Study NCT04063553 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Exercise brochure
Description: . The control group subjects will receive only standard physiotherapy care and they will be instructed to perform 1 set of exercises daily following a brochure given. The exercises in the brochure and exercises taught by the volunteers are the same. The video and brochure are available in both English and Chinese version.
Study NCT02151305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol, remifentanil
Study NCT02151305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Study NCT02011685 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home BP Telemonitoring (HBPTM)
Description: Participants will take home BP readings 3 days per week (morning and evening), one week out of every month for 12 months. BP readings will be transmitted wirelessly to a secure server. Patients' physicians will receive home BP reports via secure email before every scheduled appointment for the duration of the study to facilitate necessary treatment intensification and medication adjustments.
Study NCT02011685 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home BP Telemonitoring (HBPTM)
Description: Participants will take home BP readings 3 days per week (morning and evening), one week out of every month for 12 months. BP readings will be transmitted wirelessly to a secure server. Patients' physicians will receive home BP reports via secure email before every scheduled appointment for the duration of the study to facilitate necessary treatment intensification and medication adjustments.
Study NCT02011685 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurse Case Management (NCM)
Description: Participants will complete 20 counseling phone calls with a nurse case manager (NCM) during the 12-month intervention: weekly calls for Months 1-2; biweekly calls for Months 3-4; and monthly calls for Months 5-12. The NCMs will provide self-management education, medication and appointment reminders, and will facilitate patient-provider communication. They will counsel patients on specific self-management behaviors using problem solving and motivational interviewing techniques. Target behaviors will include dietary changes, physical activity, weight loss, medication adherence, and smoking cessation. NCMs will also review patients' clinical information and provide feedback about abnormal lab results, and will communicate with the patient's physician as needed (e.g., regarding barriers).
Study NCT01010412 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound (Sonosite Titan T-shaped ultrasound probe)
Description: Ultrasonography will allow direct visualization of nerves. As local anesthetic is injected, it can be seen surrounding the nerve.
Study NCT01010412 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Electrical Nerve Stimulation (Stimuplex (B Braun) needle)
Study NCT00630825 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2189265
Study NCT00630825 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT00521820 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Description: Pioglitazone 30 mg (titrated to 45mg with tolerance), tablets, orally once daily and glyburide placebo-matching tablets, orally, once daily for up to 24 weeks.
Study NCT00521820 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glyburide
Description: Pioglitazone placebo-matching tablets, orally, once daily and glyburide 10 mg (titrated to 15mg with tolerance), capsules, orally, once daily for up to 24 weeks.
Study NCT03182504 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nacubactam
Description: Participants will receive a single 2000 milligram (mg) intravenous (IV) infusion of nacubactam over 1.5 hours.
Study NCT03182504 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: meropenem
Description: Participants will receive a single 2000 mg IV infusion of meropenem over 1.5 hours.
Study NCT02480569 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FFR Measurement
Study NCT01045382 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells
Description: Mesenchymal stem cell injection
Study NCT01045382 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic solution
Description: Isotonic solution injection
Study NCT03794648 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile Interactive Supervised Therapy (MIST)
Description: MIST system will send a reminder notification (via push or SMS) to participants 10 to 15 minutes before the scheduled time for taking their medication. Participants will then activate the recording function of the MIST app on their phone, and record themselves taking their medication.Participants will be asked to go through a series of steps for recording the video.
Study NCT03745846 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Composite Gel Containing Black Raspberry
Description: Composite Gel Containing Black Raspberry 3,000/preparation
Study NCT03745846 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Composite Gel Containing Black Raspberry-placebo
Study NCT06213584 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conservative rehabilitation
Description: Hotpack + TENS + streching exercises
Study NCT06213584 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mullgan mobilization techniques
Description: Passive mobilization techniques during active movements
Study NCT06213584 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pnf
Description: hold relax active movements
Study NCT01168414 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ganfort
Description: Fixed combination of Bimatoprost and Timolol (BTFC; Ganfort (300 microgram + 5 mg/ml eyedrops solution)
Study NCT01168414 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duotrav
Description: Fixed combination of Travoprost and Timolol (TTFC; Duotrav (40 micrograms + 5 mg/ml eyedrops solution)
Study NCT01174381 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: lifestyle modification
Description: Lifestyle modification for six months
Study NCT04228679 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Erbium laser
Description: Erbium laser device
Study NCT04228679 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Laser
Description: Sham laser device
Study NCT03211884 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Problem-Solving Thearpy
Description: The problem-solving therapy (PST)-based intervention consists of nine, 60-90 minute educational sessions conducted face-to-face via the Internet (through video conferencing software) approximately 2 weeks apart. After attending a preliminary 15 minute meet \& greet session, participants received written and verbal education about solving everyday problems. Together, the participant and interventionist complete the 7-steps to solve at least one problem together before ending the training. Participants keep a record of their problem-solving efforts between sessions and questions they had related to the application of PST. These records were used as a basis for discussion during the PST training sessions.
Study NCT00509951 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: One-session exposure treatment
Description: Participants receiving OST will attend one extended treatment session, lasting up to 3 hours in duration. During this session, the child will be taught a number of cognitive and behavioral skills to deal effectively with the feared situation or object. The child will also be exposed to the feared situation or object in a highly structured, safe, and controlled manner.
Study NCT00509951 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Augmented one-session exposure treatment
Description: Family-enhanced OST (augmented OST) involves the parents of affected children and provides the parents with strategies to assist their children in overcoming phobias. Participants receiving augmented OST will attend the same type of extended treatment session, but, in addition, their parent or guardian will attend a 3-hour session.
Study NCT02593097 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Metformin 500mg twice daily
Study NCT02593097 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Matching Placebo twice daily
Study NCT01255345 — intervention group
Intervention type: OTHER
Intervention: Chronic pelvic pain
Description: A physioterapeutic examination of abnormal muscular findings, i.e tonus, elasticitt and strength, in the pelvic area connected to female CPP.
Study NCT00887575 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: IV infusion per institutional guidelines on Days 1, 8 and 15 of a 28 day cycle as follows depending on dose level (DL): DL1- 70 mg/m2, DL2- 80 mg/m2, DL3- 80mg/m2, DL4- 80mg/m2, DL-1- 70mg/m2, DL-2- 60mg/m2
Study NCT00887575 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: IV infusion per institutional guidelines Day 1 of a 28 day cycle as follows depending on dose level (DL): DL1- AUC=5, DL2- AUC=5, DL3- AUC=6, DL4- AUC=6, DL-1- AUC=4, DL-2- AUC=4
Study NCT00887575 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sunitinib
Description: By mouth (PO) once daily on days 1-21 of a 28 day cycle as follows depending on dose level (DL): DL1- 25mg, DL2-25mg, DL3- 25mg, DL4- 37.5mg, DL-1- 25mg, DL-2- 25mg. Maintenance therapy of 25mg daily
Study NCT01602211 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Internet-Based Intervention
Description: Receive full access to INSPIRE
Study NCT01602211 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Internet-Based Intervention
Description: Receive access to an annotated list of existing resources for transplant and cancer survivors and delayed access to INSPIRE site
Study NCT01602211 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medical Chart Review
Description: Ancillary studies
Study NCT01602211 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT01602211 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03227744 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Group therapy
Description: Twelve 1-hour group therapy sessions with a licensed psychologist for prostate-cancer related anxiety.
Study NCT03227744 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Surveys
Description: MAX-PC, GAD and FACT-P
Study NCT03227744 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Surveys
Description: MAX-PC, GAD and FACT-P
Study NCT03460444 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: MCT Oil Supplementation
Description: Participants consume MCT oil (97-99% octanoic acid) twice per day for 14 days. Dosing will begin at 5ml/dose for Days 1-2, 10ml for Days 3-4, and 15ml for the remainder of the intervention.
Study NCT04051645 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Breathing through a system with adjustable flow resistance
Description: The proband will breathe through the adjustable flow resistance within the experiment, to which a standard D-lite Flow sensor will be connected, and the airway pressure, flow, minute consumption, oxygen and carbon dioxide, tidal volume, oxygen saturation of peripheral blood and oxygen and carbon dioxide concentrations in both inspired and expired air will be recorded using the Datex-Ohmeda S/5 Patient Monitor vital signs monitor.~The proband will breathe through the flow resistors in a randomized order, and pre-defined three-minute pauses will be maintained between measurements with different flow resistance values. Each measurement will take approximately two minutes and will be measured on ten different flow resistances.
Study NCT02295293 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rhus Coriaria L. (Rhus)
Description: 500 mg of Rhus Coriaria L. (Rhus) powder in capsule: 1 capsule twice daily for 6 weeks
Study NCT02295293 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsule: 1 capsule twice daily for 6 weeks
Study NCT00784277 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: oxycodone CR
Description: flexible dose tablets and capsules 2 x a day for 28 days (20-60mg/day)
Study NCT03718208 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Paediatric Formula
Description: Children will switch over to the low calorie paediatric feed. Intake diaries and tolerance diaries will be completed for one week.
Study NCT00784277 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: oxycodone IR
Description: 10mg for 14 days
Study NCT00784277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tapentadol ER (CG5503)
Description: flexible dose tablets and capsules 2 x a day for 28 days (100-500mg/day)
Study NCT00784277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tapentadol IR (CG5503)
Description: 50mg for 14 days
Study NCT00784277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tapentadol IR (CG5503)
Description: 75mg for 14 days
Study NCT00784277 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 1 capsule for 14 days
Study NCT00784277 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Tablets and capsules 2 x a day for 28 days
Study NCT02137603 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patients discharged home the same day following appendectomy
Description: Patients are discharged to home on the same day following appendectomy with oral antibiotics.
Study NCT02041897 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: EUS-FNA
Description: Only one puncture will be performed. First the fluid will be aspirated out for biochemical analysis and cytology. Then the tissue will be aspirated out from the solid part of the lesion for pathology.
Study NCT02916524 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Semantic Feature Analysis (SFA)
Description: SFA training entails having the speech-language pathologist (SLP) guide the participant through generation of pertinent semantic features for pictured treatment items (e.g., category membership, physical description, location of item in context, action associated with item). Treatment is applied to a set of items in the context of single-subject, multiple baseline designs so that replication of treatment effects could be evaluated within and across participants. Treatment will be administered two times per week until prescribed accuracy levels were met during treatment probes or a maximum number of treatment sessions was completed.
Study NCT02916524 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Semantic Feature Analysis (SFA)
Description: SFA training entails having the speech-language pathologist (SLP) guide the participant through generation of pertinent semantic features for pictured treatment items (e.g., category membership, physical description, location of item in context, action associated with item). Treatment is applied to a set of items in the context of single-subject, multiple baseline designs so that replication of treatment effects could be evaluated within and across participants. Treatment will be administered two times per week until prescribed accuracy levels were met during treatment probes or a maximum number of treatment sessions was completed.
Study NCT01822093 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cytovir-ADV
Description: A single dose 1x10e4 CD3+ T cells/kg patient weight of Cytovir ADV is prescribed to patients on exhibiting two consecutive PCR positive Adenovirus viraemia results > 1000 copies/ml. Patients are followed up by continued monitoring of Adenovirus viraemia results. If patients exhibit uncontrolled ADV viraemia at ≥ 4 weeks following the first cell dose, they will be prescribed a second cell dose of 10e5 CD3+ T cell/kg. Patients will be monitored for 6 months following infusion of Cytovir ADV.~This is a feasibility/pilot study and has no control group
Study NCT02630927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AG-519
Description: AG519 will be tested.
Study NCT02630927 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: AG-519
Description: AG519 will be tested.
Study NCT02630927 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be tested.
Study NCT00191984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pemetrexed
Description: 400 mg/m\^2, intravenous (IV), every 14 days x 12 cycles
Study NCT00191984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: irinotecan
Description: 180 mg/m\^2, intravenous (IV), every 14 days x 12 cycles